NCT05204186
- Conditions
- Bladder Cancer, Comorbidity, Deep Learning, +11 more
- Locations
-
- CHU Amiens Picardie Amiens, Picardie, France
Clinical trial condition
Bladder Cancer
Explore clinical trials studying Bladder Cancer. Study availability and eligibility vary by location and protocol.
771 public trials
174 recruiting studies
Bladder Cancer trial results
NCT07144319
- Conditions
- Bladder Cancer, Carcinoma, Female Urogenital Diseases, +14 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Regents of the University of Michigan Ann Arbor, Michigan, United States
- Rutgers Cancer Institute New Brunswick, New Jersey, United States
- Oslo University Hospital Oslo, Norway
Recruiting
DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr
NCT04106115
- Conditions
- Bladder Cancer, Carcinoma, Female Urogenital Diseases, +13 more
- Locations
-
- Cambridge University NHS FT Cambridge, United Kingdom
- Guy's and St Thomas' NHS Foundation Trust London, United Kingdom
- Royal Free London NHS FT London, United Kingdom
- The Royal Marsden NHS Foundation Trust London, United Kingdom
NCT04235777
- Conditions
- Adenocarcinoma, Bladder Cancer, Carcinoma, +20 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT06851663
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +64 more
- Locations
-
- Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, China
Recruiting
The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy
NCT06388720
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- National Cancer Center Goyang-si, South Korea
NCT07475403
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
- Locations
-
- The Second Hospital of Tianjin Medical University Tianjin, China
- Tianjin Hospital Tianjin, China
- Xingtai People's Hospital Xingtai, China
NCT07602010
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
- Locations
-
- Oslo University Hospital Oslo, Norway
Recruiting
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
NCT06503146
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +57 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT07581496
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Universitätsspital Basel Basel, Switzerland
- Luzerner Kantonsspital Lucerne, Switzerland